CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of obesity across the globe
3.4.1.2. Increase in number of employees working in shifts and under stressful work conditions
3.4.1.3. Technological advancements in sleep apnea diagnostic devices

3.4.2. Restraints

3.4.2.1. High cost associated with the sleep apnea diagnostic devices
3.4.2.2. Lack of awareness among patients regarding sleep apnea

3.4.3. Opportunity

3.4.3.1. Untapped markets in developing economies

CHAPTER 4: SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Polysomnography device (PSG)

4.2.1. Key trends and opportunities
4.2.2. List of Distributors
4.2.3. Market size and forecast
4.2.4. Market analysis, by country

4.2.4.1. Clinical PSG Device
4.2.4.2. Market size and forecast
4.2.4.3. Ambulators PSG Device
4.2.4.4. Market size and forecast

4.3. Sleep apnea screening device

4.3.1. Key trends and opportunities
4.3.2. List of ditributors
4.3.3. Market size and forecast
4.3.4. Market analysis, by country

4.4. Actigraphy monitoring device

4.4.1. Key trends and opportunities
4.4.2. List of distributors
4.4.3. Market size and forecast
4.4.4. Market analysis, by country

4.5. Respiratory polygraph

4.5.1. Key trends and opportunities
4.5.2. List of distributors
4.5.3. Market size and forecast
4.5.4. Market analysis, by country

4.6. Oximeter

4.6.1. Key trends and opportunities
4.6.2. List of distributors
4.6.3. Market size and forecast
4.6.4. Market analysis, by country
4.6.5. Finger Tip Oximeter

4.6.5.1. Market size and forecast

4.6.6. Handheld Oximeter

4.6.6.1. Market size and forecast

4.6.7. Wrist-worn Oximeter

4.6.7.1. Market size and forecast

4.6.8. Tabletop Oximeter

4.6.8.1. Market size and forecast

CHAPTER 5: SLEEP APNEA DIAGNOSTICS MARKET, BY END USER

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals & sleep laboratories

5.2.1. List of distributors
5.2.2. Market size and forecast
5.2.3. Market analysis, by country

5.3. Home care settings

5.3.1. List of distributors
5.3.2. Market size and forecast
5.3.3. Market analysis, by country

CHAPTER 6: SLEEP APNEA DIAGNOSTICS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key trends and opportunities
6.2.2. List of distributors
6.2.3. North America market size and forecast, by country

6.2.3.1. U.S. market size and forecast, by product
6.2.3.2. U.S. market size and forecast, by end user
6.2.3.3. Canada market size and forecast, by product
6.2.3.4. Canada market size and forecast, by end user
6.2.3.5. Mexico market size and forecast, by product
6.2.3.6. Mexico market size and forecast, by end user

6.2.4. North America market size and forecast, by product
6.2.5. North America market size and forecast, by end user

6.3. Europe

6.3.1. Key trends and opportunities
6.3.2. List of distributors
6.3.3. Europe market size and forecast, by country

6.3.3.1. Germany market size and forecast, by product
6.3.3.2. Germany market size and forecast, by end user
6.3.3.3. UK market size and forecast, by product
6.3.3.4. UK market size and forecast, by end user
6.3.3.5. France market size and forecast, by product
6.3.3.6. France market size and forecast, by end user
6.3.3.7. Italy market size and forecast, by product
6.3.3.8. Italy market size and forecast, by end user
6.3.3.9. Spain market size and forecast, by product
6.3.3.10. Spain market size and forecast, by end user
6.3.3.11. Rest of Europe market size and forecast, by Product
6.3.3.12. Rest of Europe market size and forecast, by end user

6.3.4. Europe market size and forecast, by product
6.3.5. Europe market size and forecast, by end user

6.4. Asia-Pacific

6.4.1. Key trends and opportunities
6.4.2. List of distributors
6.4.3. Asia-Pacific market size and forecast, by country

6.4.3.1. Japan market size and forecast, by product
6.4.3.2. Japan market size and forecast, by end user
6.4.3.3. China market size and forecast, by product
6.4.3.4. China market size and forecast, by end user
6.4.3.5. India market size and forecast, by product
6.4.3.6. India market size and forecast, by end user
6.4.3.7. Australia market size and forecast, by product
6.4.3.8. Australia market size and forecast, by end user
6.4.3.9. Rest of Asia-Pacific market size and forecast, by product
6.4.3.10. Rest of Asia-Pacific market size and forecast, by end user

6.4.4. Asia-Pacific market size and forecast, by product
6.4.5. Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. List of distributors
6.5.3. LAMEA market size and forecast, by country

6.5.3.1. Brazil market size and forecast, by product
6.5.3.2. Brazil market size and forecast, by end user
6.5.3.3. South Africa market size and forecast, by product
6.5.3.4. South Africa market size and forecast, by end user
6.5.3.5. Saudi Arabia market size and forecast, by product
6.5.3.6. Saudi Arabia market size and forecast, by end user
6.5.3.7. Rest of LAMEA market size and forecast, by product
6.5.3.8. Rest of LAMEA market size and forecast, by end user

6.5.4. LAMEA market size and forecast, by product
6.5.5. LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

7.1. CADWELL INDUSTRIES INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio

7.2. DEVILBISS HEALTHCARE

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio

7.3. KONINKLIJKE PHILIPS N.V. (PHILIPS)

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key Strategic Moves:

7.4. MEDTRONIC PLC.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segment
7.4.4. Product portfolio
7.4.5. Business performance

7.5. MINDRAY MEDICAL INTERNATIONAL LIMITED

7.5.1. Company overview
7.5.2. Operating business segment

7.6. NATUS MEDICAL INCORPORATED

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Operating business segments
7.6.5. Business performance

7.7. NIHON KOHDEN CORPORATION

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance

7.8. RESMED INC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segment
7.8.4. Product portfolio
7.8.5. Business performance

7.9. SMITHS GROUP PLC. (SMITHS MEDICAL)

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key Strategic Moves:

7.10. SOMNOMEDICS GmbH

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio